Epitel

USASalt Lake CityHealthcare & MedtechSeries B

Overview

Where Epitel is now

Epitel announced a Series B round of $26M on 28 July 2026, led by Catalyst Health Ventures and Genoa Ventures.

Observed Described in the funding announcement as "provider of an AI-driven wireless brain health technology platform". Source

Latest round
Series B
Amount
$26M
Announced
28 July 2026
Headquarters
Salt Lake City, USA
Sector
Healthcare & Medtech
Investors
Catalyst Health Ventures and Genoa Ventures
Also participating
new and existing investors
Relevant leadership
CEO Steve Pacelli

Current direction Inferred

What this company is working on

Market expansionProductCommercial growthInfrastructure

Read from the company's own description of what the funding supports.

Momentum Inferred

AfterRaise Score

68
Building momentum
1 funding signal in the last 90 days
Funding recency
34/40
announced within the last 60 days
Round scale
16/25
round size relative to the market
Funding stage
18/20
Series B
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Growth timeline

What has happened so far

  • 28 July 2026
    $26M Series B
    Led by Catalyst Health Ventures and Genoa Ventures.

Observed The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

Moves

Published by the company

Share a Move

No company-published Moves yet

AfterRaise has the funding facts for Epitel from public sources. What it does not have is what the company is doing next, in the company's own words. That part only they can write.

Work here? Publish the first Move

Opportunities

Work this company has opened

No open Opportunities listed

Jobs, projects, partnerships and advisory needs appear here once the company has claimed its room and published them.

Work here? Open the first one

Open to

Who may approach Epitel

Not yet specified

Epitel has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

This room belongs to Epitel.

Claim it to publish Moves in your own words, open Opportunities, choose who may approach you, and see the offers of help you have received. Everything you publish is reviewed before it appears.

Also moving

Other Healthcare & Medtech companies

See the sector